“Reconstruction of a new batch of the vaccine will soon commence and trials are
expected to be underway early in 2005. The new batch will be tested at several
stages to ensure that the defect has been corrected. This will ensure that the
protective gene will express as expected,” said Dr Lamb. “With this news and the
recent success in gaining a $250,000 BIF grant to develop the Avian Influenza
Vaccine, we remain very optimistic that we can develop an effective vaccine
against bird flu.”
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
42.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1767 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 1177 | 1 |
View Market Depth
| Last trade - 09.19am 15/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |
Day chart unavailable